Genomics

Dataset Information

Pro-immunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy [MC38 treated with MEKi, in vitro]


ABSTRACT: Pro-immunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy [MC38 treated with MEKi, in vitro]

PROVIDER: PRJNA602919 | ENA |

REPOSITORIES: ENA